BELVIQ XR
Arena Pharmaceuticals GmbH
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86693911 |
| Registration Number | 4922297 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Allison Strickland Ricketts |
| Attorney Docket Number | APRS 1505119 |
| Law Office Assigned | M60 |
| Employee Name | SMITH, BRIDGETT G |
Timeline
| 2015-07-15 | Application Filed |
| 2016-01-05 | Published for Opposition |
| 2016-03-22 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-03-22 | Status: Live/Registered |
| 2016-03-22 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Arena Pharmaceuticals GmbH |
| Entity Statement | gesellschaft mit beschränkter haftung (gmbh) |
| Address | Untere Bruhlstrasse 4 CH-4800 Zofingen CH |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 261314 | Quadrilateral (three or more quadrilaterals); Three or more quadrilaterals |
| 261321 | Quadrilaterals that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2015-07-18 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-07-21 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2015-07-22 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2015-10-06 | 4 DOCK D:Assigned to Examiner |
| SUSPENSION LETTER WRITTEN | 2015-10-14 | 5 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2015-10-14 | 6 GNSL F:First Action |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2015-10-14 | 7 GNS3 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2015-10-28 | 8 ERSI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2015-11-16 | 9 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-11-16 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-11-16 | 11 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-11-16 | 12 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-11-30 | 13 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-12-16 | 14 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-01-05 | 15 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-01-05 | 16 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2016-03-22 | 17 R.PR A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-01-31 | 18 CRFA I:Incoming Correspondence |
| REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | 2017-04-05 | 19 CORV 1: |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2021-03-22 | 20 REM1 E:E-Mail |
| CANCELLED SEC. 8 (6-YR) | 2022-10-07 | 21 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BELVIQ XR 86693918 4908131 Live/Registered |
EISAI INC. 2015-07-15 |
 BELVIQ XR 86693911 4922297 Live/Registered |
Arena Pharmaceuticals GmbH 2015-07-15 |
 BELVIQ XR 86330779 4695303 Live/Registered |
EISAI INC. 2014-07-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 